Man Group
NAGE

Man Group’s Niagen Bioscience NAGE Stock Holding History

Man Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,105
Closed -$172K – 2625
2025
Q4 		$172K Buy
27,105
+11,239
+71% +$78.2K ﹤0.01% 2149
2025
Q3 		$148K Buy
+15,866
New +$160K ﹤0.01% 2133
2024
Q3 		– Sell
-74,309
Closed -$203K – 2260
2024
Q2 		$203K Buy
74,309
+56,764
+324% +$190K ﹤0.01% 1892
2024
Q1 		$61.1K Buy
+17,545
New +$32.5K ﹤0.01% 2083

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Man Group's NAGE Position: Q1 2026 in Review

Man Group sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 27,105 shares — an estimated $172K sold.

Man Group first reported a position in NAGE in Q1 2024 and held it in 4 quarters. The position peaked at $203K in Q2 2024. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Man Group reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 27,105 Niagen Bioscience shares in Q1 2026, an estimated $172K.
  • Man Group first reported a position in Niagen Bioscience in Q1 2024 and held it in 4 quarters.
  • Man Group's Niagen Bioscience position peaked at $203K in Q2 2024.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.